In June 2025, Greg Samios was appointed as the CEO of Wolters Kluwer Health, a leading global provider of trusted clinical technology, research, life-long learning, and evidence-based solutions that drive effective decision-making and outcomes across healthcare.
A seasoned healthcare executive with more than twenty-five years of experience, Samios served as Executive Vice President of the Health division’s two largest business units, Clinical Effectiveness and Health Learning, Research, and Practice. While a Health division leader, Samios has driven growth in Wolters Kluwer’s leading clinical decision support and clinical drug information products, UpToDate and Medi-Span. He also led the introduction of generative AI into the company’s healthcare products and solidified partnerships with leading digital health companies.
In a prior role at Wolters Kluwer, Samios served as Executive Vice President of the Legal & Regulatory U.S. business. His career experience before joining Wolters Kluwer included several health-focused positions at Elsevier spanning more than ten years. He earned a Master of Business Administration from Duke University Fuqua School of Business and graduated with a B.S. and M.S. in Engineering from the University of Rochester.
Samios earned a Master of Business Administration from Duke University Fuqua School of business and graduated from the University of Rochester with a B.S. and M.S. in Engineering. He serves as a Governing Board member of the American Chemical Society, one of the world’s largest scientific societies, and has been an advisor and mentor to several early-stage health information businesses.
LinkedIn